Dendreon (DNDN) shares -10.3% after it confirms that the SEC has opened an investigation, which...

|About: Dendreon Corporation (DNDN)|By:, SA News Editor

Dendreon (DNDN) shares -10.3% after it confirms that the SEC has opened an investigation, which could be connected to lawsuits accusing the company of misleading investors over prostate-cancer treatment Provenge.